Larimar Therapeutics, Inc.

NASDAQ:LRMR

Biotechnology

Healthcare
$3.23 +0.99%

+$0.04 today

Market cap
$337.45M
Beta
0.82
P/E (TTM)
-1.8
EPS (TTM)
-$1.95
52W Low $2.22High $6.42

Volume 1.41M

Average 1.73M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$172.50M

FY 2025 · Annual

Net Income

-$165.67M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development38.4M24.25M27.67M73.28M154.22M
Selling, General & Admin12.07M12.28M14.09M17.61M18.27M
Operating Expenses50.47M36.53M41.76M90.89M172.5M
Depreciation & Amortization326K318K311K318K350K
EBITDA(50.31M)(35.04M)(36.64M)(80.29M)(165.32M)
EBITDA Margin—————
Operating Income(50.47M)(36.53M)(41.76M)(90.89M)(172.5M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses(171K)1.17M4.81M10.29M6.82M
Income Before Tax(50.64M)(35.36M)(36.95M)(80.6M)(165.67M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(50.64M)(35.36M)(36.95M)(80.6M)(165.67M)
Net Margin—————
EPS (Basic)(2.93)(1.33)(0.84)(1.32)(2.27)
EPS (Diluted)(2.93)(1.33)(0.84)(1.32)(2.27)
Weighted Avg Shares17.16M25.76M43.9M61.26M72.95M
Weighted Avg Shares (Diluted)17.16M25.76M43.9M61.26M72.95M

LRMR Earnings Waterfall · TTM

NASDAQ:LRMR · Revenue to Net Income

Key Ratios

EPS$-2.10
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$166.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.10, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026

How much revenue does LRMR generate?

Larimar Therapeutics, Inc. (LRMR) reported $0.00 of revenue in fiscal 2025.

Is LRMR profitable?

Larimar Therapeutics, Inc. (LRMR) reported -$165.67M of net income.